Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Antiviral Res. 2020 Mar 23;177:104777. doi: 10.1016/j.antiviral.2020.104777

Fig 2. Example HBV replication inhibition and CC50 experiments.

Fig 2.

Left, Replication inhibition. Representative assays are shown. Values are the average ± standard deviation from multiple assays. Black, plus-polarity DNA; gray, minus-polarity DNA. Right, Cytotoxicity. Representative MTS assays are shown. Values are the average ± standard deviation from multiple assays. Representative assays with the nucleoside analog Lamivudine are shown for context.